This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Japan Tobacco Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Tatsuya Maekawa: Innovator in Pain Treatment
Introduction
Tatsuya Maekawa is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of pain and interstitial cystitis. His innovative approach has led to the development of a unique therapeutic agent that addresses these medical conditions.
Latest Patents
Maekawa holds a patent for a method of treating pain or interstitial cystitis using an indole compound. The patent describes a therapeutic or prophylactic agent comprising N-[2-(6,6-dimethyl-4,5,6,7-tetrahydro-H-indazol-3-yl)-1H-indol-6-yl]-N-methyl-(2S)-2-(morpholin-4-yl)propanamide or a pharmaceutically acceptable salt thereof. This innovative solution aims to provide relief for patients suffering from these ailments.
Career Highlights
Throughout his career, Tatsuya Maekawa has been associated with Japan Tobacco Inc., where he has worked alongside talented colleagues such as Yoshifumi Ueda and Mutsuyoshi Matsushita. His work has not only advanced the understanding of pain management but has also contributed to the pharmaceutical industry.
Collaborations
Due to space constraints, the details of collaborations will not be included.
Conclusion
Tatsuya Maekawa's contributions to the field of pain treatment through his innovative patent demonstrate his commitment to improving patient care. His work continues to inspire advancements in medical research and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile